FALCO HOLDINGS Co., Ltd. (4671.T)
- Previous Close
2,245.00 - Open
2,241.00 - Bid --
- Ask --
- Day's Range
2,212.00 - 2,241.00 - 52 Week Range
1,770.00 - 2,370.00 - Volume
13,700 - Avg. Volume
25,219 - Market Cap (intraday)
23.811B - Beta (5Y Monthly) 0.17
- PE Ratio (TTM)
12.24 - EPS (TTM)
182.27 - Earnings Date May 10, 2024
- Forward Dividend & Yield 80.00 (3.59%)
- Ex-Dividend Date Mar 28, 2024
- 1y Target Est
--
FALCO HOLDINGS Co., Ltd., a medical service company, provides clinical testing and dispensing pharmacy services to medical institutions and companies in Japan. It offers clinical testing services in the fields of genetic tests, biochemistry, hematology, pathology, immunology, and microbiology; and genetic testing services. The company also provides medical information technology services; and develops in vitro diagnostics for unmet medical needs. In addition, it is involved in the dispensing pharmacies and drugstores business; and development and sale of various medical chart systems, including HAYATE / NEO, a cloud-based electronic medical chart for small and medium-sized hospitals, as well as @home Dr., an electronic medical chart for bed less clinics. FALCO HOLDINGS Co., Ltd. was founded in 1962 and is headquartered in Osaka, Japan.
www.falco-hd.co.jp1,159
Full Time Employees
March 31
Fiscal Year Ends
Sector
Industry
Related News
Performance Overview: 4671.T
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 4671.T
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 4671.T
Valuation Measures
Market Cap
23.81B
Enterprise Value
14.30B
Trailing P/E
12.23
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.57
Price/Book (mrq)
0.92
Enterprise Value/Revenue
0.33
Enterprise Value/EBITDA
4.84
Financial Highlights
Profitability and Income Statement
Profit Margin
4.60%
Return on Assets (ttm)
3.34%
Return on Equity (ttm)
7.91%
Revenue (ttm)
43.35B
Net Income Avi to Common (ttm)
2B
Diluted EPS (ttm)
182.27
Balance Sheet and Cash Flow
Total Cash (mrq)
10.01B
Total Debt/Equity (mrq)
1.94%
Levered Free Cash Flow (ttm)
--
Company Insights: 4671.T
4671.T does not have Company Insights